About 1 result found for searched term "2389235-01-0" (0.12 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M45116 | NX-13 | NLR |
| Amelenodor | ||
| NX-13 is a novel oral small molecule NLRX1 agonist, which can increase oxidative phosphorylation in immune cells, decrease the differentiation of effector CD4+ T cells, and reduce the production of inflammatory cytokines in the gastrointestinal tract through activation of the NLRX1 pathway, and can be used in studies related to ulcerative colitis (UC). | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
